Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Pseudomonas aeruginosa surface receptors** encompass a variety of outer membrane proteins, including TonB-dependent receptors, porins such as OprF, adhesins (CupB, CdrA), chaperone-usher pathway components, Type V secretion system proteins, and LPS-binding sites[3][5][7][9][10]. These receptors mediate critical processes such as nutrient acquisition (e.g., heme, iron), signal transduction (notably quorum sensing via receptors like LasR[1]), adherence to host cells, immune avoidance, and biofilm formation. Many of these surface molecules are essential virulence factors and represent important therapeutic targets for antibody-based therapies, vaccine development, or targeted drug delivery. Specific drug targeting may be challenging due to antigenic variation, redundancy, and essentiality in basic bacterial physiology; key examples include OprF (major porin, also involved in signaling), OprL, OprI, CupB fimbriae, and TonB-dependent transporters for heme and siderophore uptake[7][9][10]. These diverse receptors play fundamental roles in infection, can serve as biomarkers, and in some cases have been exploited for targeted drug delivery or immunotherapy approaches[2][10]. **Important clarification:** "Pseudomonas aeruginosa surface receptor" is not a single molecule, but refers to a heterogeneous class of functionally diverse proteins, including but not limited to porins (OprF), TonB-dependent receptors (e.g., PhuR, HasR, HxuA), adhesins, and quorum-sensing receptors (e.g., LasR)[1][7][9][10]. Precise annotation should use a specific molecular name (e.g., "Pseudomonas aeruginosa OprF" or "LasR receptor" or "PhuR heme transporter"), as "Pseudomonas aeruginosa surface receptor" is not a canonical target entity but a functional and structural category. **Therefore, is_incorrect is true** because the target name is non-specific and refers to a large group of unrelated, important outer membrane and periplasmic proteins in *P. aeruginosa*[7][9][10].
Inhibition of nutrient uptake/signaling; Cellular adhesion blockade (e.g., via antibodies); Direct bactericidal effect via cell wall permeabilization or interference with receptor function; Drug delivery (e.g., liposomal targeting to surface glycans[2]); Immunological clearance
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudomonas aeruginosa surface receptor.